Logo

spinout

Delve Bio Seeks to Commercialize UCSF Metagenomic Pathogen Test
Premium

In addition to proving clinical utility, the startup will have to navigate issues of regulatory strategy, sequencing technology, and additional indications.

CellChorus Receives $2.2M SBIR Grant From NIGMS

The funding will help support development of the University of Houston spinout's imaging-based cell analysis platform.

Delve Bio Raises $35M in Series A Financing to Develop Metagenomic Sequencing Diagnostics

The UCSF spinout's cofounders include Joe DeRisi and Charles Chiu, as well as Pardis Sabeti of Harvard University and the Broad Institute.

MGI Tech Partners With Sweden's Xpress Genomics on Single-Cell RNA-seq Tech Development

MGI has licensed single-cell RNA-seq techniques that cover the full length of a transcript from Xpress Genomics.

POC Genotyping Tests Based on Electromagnetic Detection Tech Step out From Stanford University Lab
Premium

Spinout Magic LifeScience is leading commercialization of the molecular diagnostic technology, but the tests are popping up in other clinical scenarios, too.

Dec 19, 2022

EnPlusOne Biosciences Nabs Exclusive License to RNA Synthesis Technology from Wyss Institute

Oct 12, 2022

Harvard Researchers Publish Light-Activated Spatial Transcriptomics Method
Premium

Aug 23, 2022

Harvard University, Wyss Institute License Protein Detection Technology to Spear Bio

Jun 27, 2022

UC Santa Cruz Spinout ClaretBio Pursues NGS Sample Prep Market With Focus on cfDNA, FFPE
Premium

May 20, 2022

MSK Starts Offering Pediatric Cancer Patients Whole-Genome, Transcriptome Sequencing
Premium

Apr 11, 2022

Ansa Biotechnologies Closes $68M Series A Financing

Apr 6, 2022

BioCopy Looks Towards Diagnostics With New Platform, Planned Spinoff
Premium

Mar 22, 2022

InnoSign Raises $8M in Series A Financing, Spins off From Royal Philips

Nov 23, 2021

Twist Bioscience Details Production Issues, Plans to Expand Capacity at Bay Area Facility
Premium

Apr 5, 2021

Acuity Spatial Genomics to Develop Platform for In Situ Analysis of 3D Genome Organization
Premium

Feb 3, 2021

Stanford Team Developing Low-Cost, At-Home, Molecular COVID-19 Saliva Test
Premium

Nov 2, 2020

Researchers Turn Methylated DNA Profiling Method Towards Prenatal Testing Applications
Premium

Sep 16, 2020

Tiziana Life Sciences to Spin Off StemPrintER Asset Into Separate Company

Sep 15, 2020

Seer Spins Out Disease Testing Firm PrognomIQ With $55M in VC Funding

Aug 19, 2020

Rutgers Completes $44.4M Spinout of RUCDR Infinite Biologics

Jul 27, 2020

Vizgen Plans Launch of Spatial Transcriptomics Platform Based on MERFISH Technology
Premium

Jul 27, 2020

Oncology Informatics Firm Vidence Emerges to Supply Real-World Clinical, Genomic Data to Researchers
Premium

Jun 2, 2020

Tiziana Life Sciences to Launch Spinoff to Market Breast Cancer Recurrence Assay in Europe
Premium

Jan 29, 2020

IDbyDNA Raises $20M in Series B Financing

Dec 10, 2019

Enzo Biochem Fiscal Q1 Revenues Down 5 Percent

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.